Neuberg Diagnostics Secures ₹940 Crore in Landmark Funding to Transform India’s Diagnostics Landscape

Neuberg Diagnostics Pvt. Ltd., a leading diagnostics chain founded by industry stalwart Dr. G S K Velu, has successfully raised ₹940 crore ($109.5 million) in funding from the Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited. This landmark investment represents the largest primary fundraise in the Indian diagnostics sector and marks Neuberg Diagnostics' debut private equity round, solidifying its position as a pioneer in the rapidly evolving healthcare landscape.

The infusion of funds will empower Neuberg Diagnostics to accelerate its strategic goals, with a focus on advancing personalized medicine and integrated diagnostic services. The funding will also support the company’s inorganic growth strategy, enabling it to expand its footprint across India through acquisitions and partnerships. These developments come as Neuberg Diagnostics gears up for its Initial Public Offering (IPO), underscoring its commitment to delivering accessible, high-quality diagnostic services tailored to the needs of clinicians and patients.

Strategic Growth and Expansion
Neuberg Diagnostics has consistently demonstrated its ambition to redefine diagnostics in India through strategic mergers and joint ventures. In 2024, the company integrated NEUBERG SUPRATECH REFERENCE LABORATORIES in Ahmedabad and Neuberg Anand Reference Laboratory in Bengaluru into its parent entity, streamlining operations to better serve its customers. Additionally, Neuberg formed a joint venture with Kolkata-based Pulse Diagnostics, strengthening its presence in eastern India and cementing its status as a pan-India diagnostics leader.

Leadership Vision
Dr. G S K Velu, a veteran of the healthcare industry, is the visionary behind Neuberg Diagnostics. He is also the promoter of Trivitron Healthcare and an investor in Kauvery Hospital, a leading hospital chain in Tamil Nadu. Speaking about the milestone, Dr. Velu stated:
"This landmark investment is a testament to Neuberg Diagnostics' potential to redefine the future of diagnostics in India. With this funding, we aim to scale new heights in personalized medicine and integrated diagnostics while continuing to serve our patients with world-class healthcare solutions. As we prepare for an IPO, we remain steadfast in our commitment to making diagnostics more accessible and reliable for all."

Comprehensive Diagnostic Services
Neuberg Diagnostics is renowned for its extensive portfolio of over 5,000 pathological tests and a range of health checkup packages. By leveraging cutting-edge technology and innovative practices, the company continues to set new benchmarks in diagnostic excellence, serving millions of patients across the country.

This milestone funding reaffirms Neuberg Diagnostics’ leadership in India’s healthcare sector and positions it as a transformative force driving the next wave of growth and innovation in diagnostics.